154 related articles for article (PubMed ID: 2891337)
1. HLA-DQ restriction fragment length polymorphisms in myasthenia gravis.
Bell JI; Steinman L; Toyka K; McDevitt HO
Ann N Y Acad Sci; 1987; 505():382-7. PubMed ID: 2891337
[No Abstract] [Full Text] [Related]
2. Molecular probing of disease susceptibility genes in myasthenia gravis patients: an analysis of T-cell receptor and HLA class II genes using restriction fragment length polymorphism.
Smith CI; Borgonovo L; Carlsson B; Hammarström L; Rabbitts TH
Ann N Y Acad Sci; 1987; 505():388-97. PubMed ID: 3120635
[No Abstract] [Full Text] [Related]
3. [HLA-DQ molecules associated with myasthenia gravis in Chinese patients].
Li X; Zhang KX; Fan YX; Chen XZ; Zuo J; Pan XH; Zhu DL; Geng ZC
Yi Chuan Xue Bao; 1999; 26(4):295-300. PubMed ID: 10593018
[TBL] [Abstract][Full Text] [Related]
4. DNA polymorphism of the class II genes in DR4 cells.
So A; Bodmer J
Dis Markers; 1986 Jun; 4(1-2):165-72. PubMed ID: 2898313
[TBL] [Abstract][Full Text] [Related]
5. Association of HLA-DQA1*0101/2 and DQB1*0502 with myasthenia gravis in southern Iranian patients.
Yousefipour GA; Salami Z; Farjadian S
Iran J Immunol; 2009 Jun; 6(2):99-102. PubMed ID: 19561379
[TBL] [Abstract][Full Text] [Related]
6. Specific allelic variation among linked HLA class II genes.
Amar A; Holbeck SL; Nepom GT
Transplantation; 1987 Dec; 44(6):831-5. PubMed ID: 2892292
[TBL] [Abstract][Full Text] [Related]
7. HLA-DQ polymorphism analyzed by sequential restriction endonuclease DNA digestion.
Trucco M; Rosenshine S; Cascino I; Duquesnoy RJ
Immunogenetics; 1986; 24(3):184-90. PubMed ID: 2875943
[TBL] [Abstract][Full Text] [Related]
8. Polymorphism at the HLA-DQ locus determines susceptibility to experimental autoimmune myasthenia gravis.
Raju R; Zhan WZ; Karachunski P; Conti-Fine B; Sieck GC; David C
J Immunol; 1998 May; 160(9):4169-74. PubMed ID: 9574516
[TBL] [Abstract][Full Text] [Related]
9. Detection of disease-specific restriction fragment length polymorphisms in pemphigus vulgaris linked to the DQw1 and DQw3 alleles of the HLA-D region.
Szafer F; Brautbar C; Tzfoni E; Frankel G; Sherman L; Cohen I; Hacham-Zadeh S; Aberer W; Tappeiner G; Holubar K
Proc Natl Acad Sci U S A; 1987 Sep; 84(18):6542-5. PubMed ID: 2888115
[TBL] [Abstract][Full Text] [Related]
10. Myasthenia gravis with thymic hyperplasia is associated with polymorphisms in the tumor necrosis factor region.
Hjelmström P; Peacock CS; Giscombe R; Pirskanen R; Lefvert AK; Blackwell JM; Sanjeevi CB
Ann N Y Acad Sci; 1998 May; 841():368-70. PubMed ID: 9668261
[No Abstract] [Full Text] [Related]
11. Relationship between DQ alpha and DQ beta RFLP and cell surface polymorphisms of class II HLA antigens.
Cascino I; Rosenshine S; Turco E; Marrari M; Duquesnoy RJ; Trucco M
J Immunogenet; 1986; 13(5-6):387-400. PubMed ID: 2887620
[TBL] [Abstract][Full Text] [Related]
12. Different HLA DR-DQ associations in subgroups of idiopathic myasthenia gravis.
Carlsson B; Wallin J; Pirskanen R; Matell G; Smith CI
Immunogenetics; 1990; 31(5-6):285-90. PubMed ID: 1973409
[TBL] [Abstract][Full Text] [Related]
13. Restriction fragment length polymorphism in Felty's syndrome.
Sansom DM; Bidwell JL; Klouda PT; Maddison PJ
Dis Markers; 1986 Jun; 4(1-2):185-9. PubMed ID: 2898315
[TBL] [Abstract][Full Text] [Related]
14. Myasthenia gravis is associated with two DQ alpha/beta heterodimers.
Khalil I; Berrih-Aknin S; Lepage V; Lost MN; Gajdos P; Charron D; Hors J; Degos L
Ann N Y Acad Sci; 1993 Jun; 681():573-4. PubMed ID: 8357201
[No Abstract] [Full Text] [Related]
15. Polymorphic amino acid domains of the HLA-DQ molecule are associated with disease heterogeneity in myasthenia gravis.
Hjelmström P; Giscombe R; Lefvert AK; Pirskanen R; Kockum I; Landin-Olsson M; Sanjeevi CB
J Neuroimmunol; 1996 Apr; 65(2):125-31. PubMed ID: 8964894
[TBL] [Abstract][Full Text] [Related]
16. Molecular aspects of HLA class II and some autoimmune diseases.
Lepage V; Lamm LU; Charron D
Eur J Immunogenet; 1993 Jun; 20(3):153-64. PubMed ID: 8338813
[No Abstract] [Full Text] [Related]
17. HLA-DR, DQ, and DX alpha RFLPs and their associations with serologically defined HLA-DR and -DQ antigens.
Awad J; Navarrete C; Sachs JA; Festenstein H; Cassell PG; Niven MJ; Hitman G
Immunogenetics; 1988; 27(1):73-6. PubMed ID: 2890578
[No Abstract] [Full Text] [Related]
18. Association of HLA-DR/DQ polymorphism with myasthenia gravis in Tunisian patients.
Fekih-Mrissa N; Klai S; Zaouali J; Gritli N; Mrissa R
Clin Neurol Neurosurg; 2013 Jan; 115(1):32-6. PubMed ID: 22521184
[TBL] [Abstract][Full Text] [Related]
19. HLA class II antigens and DNA restriction fragment length polymorphism in myasthenia gravis in Japan.
Morita K; Moriuchi J; Inoko H; Tsuji K; Arimori S
Ann Neurol; 1991 Feb; 29(2):168-74. PubMed ID: 1672809
[TBL] [Abstract][Full Text] [Related]
20. HLA-DR beta, -DQ alpha, and -DQ beta restriction fragment length polymorphisms in multiple sclerosis.
Haegert DG; Michaud M; Schwab C; Tansey C; Décary F; Francis G
J Neurosci Res; 1989 May; 23(1):46-54. PubMed ID: 2568496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
